Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Treatment of chronic hepatitis C in a state correctional facility.

    Bernstein D.

    Ann Intern Med. 2004 Jan 20;140(2):150-1; author reply 151. No abstract available. PMID: 14734350 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Adopting more systematic approaches to hepatitis C treatment in correctional facilities.

    Hammett TM.

    Ann Intern Med. 2003 Feb 4;138(3):235-6. No abstract available. PMID: 12558365 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Treatment of chronic hepatitis C--ribavirin plus interferon versus interferon. An analysis of a systematic Cochrane review]

    Laursen AL, Vilstrup H.

    Ugeskr Laeger. 2006 Nov 27;168(48):4209-12. Review. Danish. No abstract available. PMID: 17147946 [PubMed - indexed for MEDLINE]Related articles

    4.

    WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

    Gluud LL, Krogsgaard K, Gluud C.

    Cochrane Database Syst Rev. 2007 Jul 18;(2):CD002234. Review.PMID: 17636700 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil]

    Alves AV, de Azevedo AP, Perin C, Ramos GZ, Brandão AB, de Mattos AA, de Almeida PR.

    Arq Gastroenterol. 2003 Oct-Dec;40(4):227-32. Epub 2004 May 31. Portuguese. PMID: 15264044 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Treatment for hepatitis C virus associated cryoglobulinemia with interferon alpha and ribavirin]

    Altuna L, Fernández J, Castiella A.

    Rev Esp Enferm Dig. 2005 Jul;97(7):531-2. Spanish. No abstract available. PMID: 16262533 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.

    Husa P, Roznovsky L, Smejkal P, Husova L, Penka M, Dite P.

    Hepatogastroenterology. 2005 Sep-Oct;52(65):1541-4.PMID: 16201114 [PubMed - indexed for MEDLINE]Related articles

    8.

    State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.

    Jurczyk K, Karpińska E, Wawrzynowicz-Syczewska M, Morańska I, Noceń I, Chlubek D, Boroń-Kaczmarska A.

    Hepatogastroenterology. 2008 Mar-Apr;55(82-83):557-61.PMID: 18613407 [PubMed - indexed for MEDLINE]Related articles

    9.

    Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.

    Papastathopoulos K, Bouzas E, Naoum G, Vergados I, Tsiodras S.

    J Infect. 2006 Feb;52(2):e59-61. Epub 2005 Jun 13.PMID: 15951019 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment of hepatitis C virus: the first decade.

    Poynard T.

    Semin Liver Dis. 2004;24 Suppl 2:19-24. Review.PMID: 15346242 [PubMed - indexed for MEDLINE]Related articles

    11.

    Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.

    Liao YR, Yen CP, Lin CC, Fu LS, Chiu CC, Chi CS.

    J Microbiol Immunol Infect. 2004 Feb;37(1):67-70.PMID: 15060691 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.

    Pojoga C, Dumitraşcu DL, Pascu O, Grigorescu M.

    J Gastrointestin Liver Dis. 2006 Mar;15(1):31-5.PMID: 16680230 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.
    14.

    Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin.

    Khokhar N.

    J Gastroenterol Hepatol. 2004 Apr;19(4):471-2. No abstract available. PMID: 15012792 [PubMed - indexed for MEDLINE]Related articles

    15.

    Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

    Figlerowicz M, Sluzewski W, Kowala-Piaskowska A, Mozer-Lisewska I.

    Eur J Pediatr. 2004 Apr;163(4-5):265-7. Epub 2004 Feb 27. No abstract available. PMID: 14991399 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting.

    Sabbatani S, Giuliani R, Manfredi R.

    Braz J Infect Dis. 2006 Aug;10(4):274-8.PMID: 17293911 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.

    Napoli N, Giannelli G, Parisi CV, Antonaci A, Maddalena G, Antonaci S.

    New Microbiol. 2005 Jan;28(1):13-21.PMID: 15782622 [PubMed - indexed for MEDLINE]Related articles

    19.

    High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.

    Wartelle-Bladou C, Arpurt JP, Renou C, Pariente A, Pillon D, Nalet B, Picon M, Glibert A, Chousterman M, Grasset D, Morin T, Bernard P, Fischer D, Ramdani M, Lagier E, Rotily M; Viral Hepatitis Group of the ANGH.

    Gastroenterol Clin Biol. 2006 Apr;30(4):525-32.PMID: 16733374 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study.

    Elefsiniotis IS, Fotos NV, Pantazis KD, Papadeli D, Mavrogiannis C.

    Hepatogastroenterology. 2007 Apr-May;54(75):2 p preceding table of contents. No abstract available. PMID: 17591034 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data